. Author manuscript; available in PMC: 2015 Mar 3.

Published in final edited form as: Respir Care. 2012 Dec 4;58(8):1291–1298. doi: 10.4187/respcare.02155

Table 4. Comparison of Outcomes by Cohort.

	Control Cohort mean (range)	Rehabilitation Cohort mean (range)	P
FEV₁ (% predicted) at 3 months²⁷	36 (25–44)	35 (21–43)	.65
FEV₁ (% predicted) at 12 months²⁷	59 (43–66)	52 (34–70)	.66
Best FEV₁ (% predicted), any time in the first 12 months²⁷	60 (43–69)	57 (43–70)	.80
Walk distance at discharge, m	213 (0–457)	780 (91–1,829)	.14
Total hospital stay, d	98 (51–151)	49 (31–63)	.05
Total ICU stay, d	49 (39–60)	27 (22–33)	.01
Days until free of mechanical ventilation for 48 h, post-transplant, d	34 (22–54)	4 (1–11)	.01
ICU stay post-transplant, d	45 (34–56)	11 (6–21)	.01
Days until tracheostomy removal, post-transplant, d	73 (44–104)	30 (13–46)	.04
Hospital stay, post-transplant, d	80 (45–110)	26 (13–33)	.01